RGCC Testing Clinic in Whitby

At NP Health Clinic we look to equip all our patients with the most robust, reliable, and accurate information about cancer so they can choose treatments that will work best for them based on their individual situations. 

Cancer is different in everyone, so we don’t believe that one treatment is the solution for all. There is a way to better understand what your body responds to best based on your current state and/or makeup. 


The reason we recommend RGCC to our patients is due to the variety of tests available that are designed to discover, analyze, and screen cancer cells at every step of the disease and to provide the vital information we need so that we can help our patients identify the best and most effective cancer treatments and therapies for them. 


RGCC testing allows us to determine the load, how much cancer is in the body, and the risk of it spreading or returning. There are tests to monitor patient's progress and it tells us if a certain type of Chemotherapy or natural substance can kill their specific cancer cells and can also determine whether late-stage therapies like vaccines or immune therapies will be effective. 


There are two categories that these tests fall under: Circulating tumor cell tests (CTCs) and Liquid Biopsies. 


To give you a bit on both of these tests and how they work: 


The Circulating Tumor (CTC) tests detect CTCs in the blood or lymph. These are cells that have detached from the original tumor and passed into the blood. The lymph system or, another part of the body with the potential to create a second tumor. 


The Liquid biopsy is a non-invasive blood test that requires no surgical intervention. It can detect circulating tumor cells and circulating free DNA in the blood. It has the potential to identify and diagnose certain forms of cancer and can also be used to monitor cancer’s progression in our patients. 


Although the CTC tests are not yet 100%, they have made significant progress in detecting and isolating these cells. Studies have shown that in people with certain types of cancer – of the breast, prostate, pancreas, colon, and skin – the CTC test is 87% sensitive and 83% specific for CTC. This means the test returns a result of 87% accuracy and will correctly return a negative result 83% of the time. Which is just amazing and it continues to be improved. 


Reference: https://www.rgcc-group.com/about-rgcc-tests/

  • RGCC Testing - Inquire within the clinic for pricing

    We have a patient who was a woman named Jane who had been feeling unwell for several months. She had come into our clinic to see our NP, who had run some tests and found that she had a tumor in her breast. Jane was devastated by the news, but she was determined to fight the cancer and beat it.


    The NP recommended that she undergo RGCC testing, which would evaluate the levels of circulating tumor cells and cancer stem cells in her bloodstream. Jane agreed to the test, and the results showed that she had a high number of CTCs and CSCs in her blood, indicating that the cancer was aggressive and had spread beyond her breast.


    Armed with this information, Jane's NP was able to tailor her treatment plan to her specific needs. She underwent surgery to remove the tumor, followed by chemotherapy and radiation therapy. Her NP monitored her progress using RGCC testing, and they were able to see that the treatment was working - the number of CTCs and CSCs in her blood was decreasing.


    After several months of treatment, Jane's RGCC test showed that she had no more detectable cancer cells in her bloodstream. Her NP was pleased with her progress and recommended that she continue with regular check-ups to monitor for any signs of recurrence.


    Thanks to the RGCC testing, Jane was able to get a better understanding of her cancer and receive personalized treatment that was tailored to her specific needs. She was able to fight the cancer and ultimately overcome it, and she was grateful for the advanced technology that had helped her along the way.

Book an Appointment

FAQs

Here are some of the Frequently Asked Questions about RGCC Testing

  • What types of tests does RGCC offer?

    RGCC developed a series of tests that can be used to detect, analyze, and screen cancerous cells. 

    We offer tests to detect early cancer signs, monitor cancers already diagnosed, and give personalized advice on the best combination of cancer therapies and treatments.

  • How is the RGCC test performed?

    Using a flow cytometry technique, RGCC isolates CTCs to obtain a sample of cells that are 97-99% pure and 99% viable for testing purposes such as molecular analyses, immunophenotyping, gene expression tests, and sensitivities against various agents.

  • How can RGCC testing benefit cancer patients?

    RGCC tests can identify treatment options with fewer side effects and less toxicity, minimizing their impact on a patient's quality of life. 

    RGCC tests can also track the effectiveness of treatment and detect early recurrence signs by monitoring CTC levels.

  • What can RGCC testing reveal?

    RGCC tests can reveal a lot of information about a tumor. It can be used to determine the genetic profile of a tumor, including mutations and alterations.

    The test also helps physicians to make informed decisions regarding potential interventions to stop metastasis.